Latest Prostate cancer Stories
A landmark DNA study in Iceland has resulted in an unprecedented look at an entire country’s genetic makeup, discovering several previously unknown mutations that could cause a vast array of different health problems, but regulations prevent some of that data from being used.
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
National recruitment firm Slone Partners is pleased to announce the placement of Michael Hoffman as Director of National Accounts at Metamark Genetics. Boston
DALLAS, March 26, 2015 /PRNewswire/ -- According to a new market research report "Tumor Ablation Market by Procedure Volume, Technology (RF, Microwave, Cryoablation, Others),
DALLAS, March 25, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Nocturia - Pipeline Review, H1 2015" therapeutic market research report provides an overview of the Nocturia's
PORTLAND, Oregon, March 25, 2015 /PRNewswire/ -- Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types,
NEW YORK, March 25, 2015 /PRNewswire/ -- The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according
BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies
SAN JOSE, Calif., March 24, 2015 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that it has submitted a 505(b)(2) New Drug Application (NDA) to the U.S.
TOKYO and SAN FRANCISCO, March 24, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.
- An armed gangster.
More Images (2 images) »